https://www.selleckchem.com/pr....oducts/bgj398-nvp-bg
This work aims to present a nuclear medicine imaging service's data regarding applying positron emission-computing tomography (PET/CT) scans with the radiopharmaceutical 68Ga-PSMA-HBED-CC (68Ga-PSMA-11) to diagnose prostate cancer clinical relapse. Eighty patients with a mean age of 68.26 years with an average prostatic-specific antigen blood level of 7.49 ng/ml (lower concentration = 0.17 ng/ml) received 68Ga-PSMA-11 intravenously, and full-body images of PT-CT scanning were obtained. Of the total of patients admitted to the
Like
Comment
Share
